| Laboratory and instrumental tests | Doctors, n (%) | p | ||
| Outpatient, n = 336 | Hospitals, n = 54 | Surgeons, n = 19 | ||
| blood amylase/lipase | 291 (86.6) | 48 (88.9) | 18 (94.7) | 0.545 |
| coprogram | 221 (65.8) | 36 (66.7) | 7 (36.8) | 0.135 |
| glucose tolerance test | 102 (30.4) | 22 (40.7) | 3 (15.8) | 0.105 |
| fecal elastase | 133 (39.6) | 32 (59.3) | 6 (31.6) | 0.016 |
| tumor markers | 39 (16.1) | 10 (19) | 4 (12) | 0.477 |
| availability of lab methods | 161 (27.5) | 19 (44) | 12 (14) | 0.111 |
| CT | 81.8 (15.6) | 81.5 (29) | 73.7 (13) | 0.637 |
| CT with intravenous contrast | 53 (15.8) | 9 (16.7) | 8 (42.1) | 0.061 |
| MRI | 114 (33.9) | 22 (40.7) | 5 (26.3) | 0.782 |
| MRCP | 70 (20.8) | 13 (24.1) | 2 (10.5) | 0.456 |
| endoEUS | 24 (7.1) | 1 (1.9) | 0 (0) | 0.433 |
| availability of instrumental diagnostic methods | 150 (44.6) | 25 (46.3) | 11 (57.9) | 0.47 |